HansMSpiegelMD

Physician

Dr. Spiegel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
HJF-DAIDS/NIAID/NIH
5601 Fishers Lane
North Bethesda, MD 20852
Phone+1 240-292-4633

NYU Grossman School of MedicineResidency, Pediatrics, 1995 - 1999
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 1992 - 1995
Freie University Berlin Faculty of MedicineClass of 1985

PubMed

ACTG 219c: Pediatric LATE Outcome Protocol, Version 30 HIV/AIDSNational Center For Research Resources2007–2008
P1030: A Phase I/II Study Of Lopinavir/Ritonavir In HIV-1 Infected Infants <6National Center For Research Resources2006
HIV Specific Immune Responses And Disease Progression In Pediatric HIV-1 InfectiNational Center For Research Resources2006
ACTG 219c: Pediatric LATE Outcome Protocol, Version 40National Center For Research Resources2006
Pactg P1006: The Effects Of Highly Active Antiretroviral Therapy (HAART)National Center For Research Resources2005–2006
Pactg 351 Phase 1/11trial Of Cd4-1gg2 Hiv-Infected ChilNational Center For Research Resources2005
Pactg 1045: Morphologic &Metabolic Abnormality In Hiv-Infect &Uninfect ChildNational Center For Research Resources2005
Pactg 1030: Phase I/II Study Of Lopinavir/Ritonavir InNational Center For Research Resources2005
Pactg 1010: Antiretroviral Therapy On Body CompositionNational Center For Research Resources2005
P1025: Perinatal Core Protocol, Version 20National Center For Research Resources2005
ACTG 219c: Pediatric LATE Outcomes Protocol, Version 40National Center For Research Resources2005
Washington D.C. Consortium Pediatric AIDS Clinical TrialNational Institute Of Allergy And Infectious Diseases2001–2002